514 web-programmer-developer-university-of-liverpool PhD scholarships in United Kingdom
Sort by
Refine Your Search
-
Listed
-
Employer
- ;
- Cranfield University
- University of Nottingham
- ; Swansea University
- ; The University of Manchester
- ; University of Birmingham
- University of Manchester
- ; University of Nottingham
- ; University of Exeter
- ; Newcastle University
- ; University of Southampton
- University of Warwick
- ; The University of Edinburgh
- ; University of Surrey
- ; University of Warwick
- University of Cambridge
- Harper Adams University
- University of Sheffield
- ; Cranfield University
- ; University of Leeds
- ; University of Oxford
- ; University of Sheffield
- UNIVERSITY OF VIENNA
- ; City St George’s, University of London
- ; Loughborough University
- Newcastle University
- The University of Manchester
- ; Brunel University London
- ; EPSRC Centre for Doctoral Training in Green Industrial Futures
- ; King's College London
- ; University of Bristol
- ; University of Cambridge
- ; University of Strathclyde
- University of Exeter
- ; Edge Hill University
- ; Manchester Metropolitan University
- ; University of Plymouth
- Abertay University
- University of Bristol
- ; Imperial College London
- ; Lancaster University
- ; UWE, Bristol
- ; University of East Anglia
- ; University of Reading
- ; University of Sussex
- Manchester Metropolitan University
- University of Birmingham
- University of Liverpool
- ; Aston University
- ; Coventry University Group
- ; Durham University
- ; Royal Northern College of Music
- ; St George's, University of London
- ; The Open University
- ; University of East London
- ; University of Greenwich
- ; University of Hertfordshire
- ; University of Huddersfield
- ; University of Hull
- ; University of Kent
- ; University of Stirling
- Aston University
- Loughborough University
- Nottingham Trent University
- Oxford Brookes University
- Swansea University
- UCL
- UNIVERSITY OF EAST LONDON
- University of Greenwich
- University of Hertfordshire
- University of Nottingham;
- University of Warwick;
- 62 more »
- « less
-
Field
-
3 years. The studentship is fully funded for 3 years. The pan-University Graduate School offers an integrated training programme to the postgraduate community within a single centre, serving to
-
from other acquired brain injuries (e.g., traumatic brain injury, brain tumour, stroke) – this work package will include quantitative and qualitative studies; second, to develop a training programme for
-
into their structure. However, we don’t yet know how to design these complex printed parts and we are still developing new leading-edge materials to grant them new capabilities. Advantages: In this PhD studentship, you
-
Manufacturing research group (CfAM) at the University of Nottingham. The student will work in world-class laboratory facilities in the CfAM engaging with interdisciplinary team with expertise in 3D printing, soft
-
Manufacturing” Programme Grant, which will place the student within an active and supportive team of 9 other PhD students, 15 postdoctoral researchers, 18 world-leading academics from 5 universities, and 11
-
, government, and wider society. In the REF2021 review of UK university research, 88% of Cranfield’s research was rated as ‘world-leading’ or ‘internationally excellent’. This project will develop a robust
-
’. Warwick University is renowned for its high-quality research and a thriving PhD program. This strong research culture enhances both the PhD student’s experience and the demand for our graduates. This PhD
-
capital cost and maintenance costs of offshore wind energy. Development of the concept has been funded by the EU H2020 programme www.xrotor-project.eu , EPSRC, the Royal Academy of Engineering and
-
to talented prospective or mid-study students towards their PhD studies in Research and Development Management. Tenable period Up to three years (pro-rata for part-time students) Continuation of award
-
, with a median survival of less than 15 months despite standard-of-care interventions such as surgery, radiotherapy, and temozolomide (TMZ). Recurrence is nearly universal, driven by intrinsic tumour